These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24574150)

  • 1. Docetaxel epimerization in silicone films: a case of drug excipient incompatibility.
    Mohsin S; Arellano IH; Choudhury NR; Garg S
    Drug Test Anal; 2014 Oct; 6(10):1076-84. PubMed ID: 24574150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
    Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
    J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols.
    Mugabe C; Liggins RT; Guan D; Manisali I; Chafeeva I; Brooks DE; Heller M; Jackson JK; Burt HM
    Int J Pharm; 2011 Feb; 404(1-2):238-49. PubMed ID: 21093563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel aqueous parenteral formulation of docetaxel using prodrugs.
    Park MH; Keum CG; Song JY; Kim D; Cho CW
    Int J Pharm; 2014 Feb; 462(1-2):1-7. PubMed ID: 24370840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of degradation impurities in docetaxel drug substance and its formulation.
    Kumar D; Tomar RS; Deolia SK; Mitra M; Mukherjee R; Burman AC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1228-35. PubMed ID: 17126518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Stent Based Delivery System for Esophageal Cancer Using Docetaxel.
    Shaikh M; Choudhury NR; Knott R; Garg S
    Mol Pharm; 2015 Jul; 12(7):2305-17. PubMed ID: 25936529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel sulforaphane-enabled self-microemulsifying delivery systems (SFN-SMEDDS) of taxanes: Formulation development and in vitro cytotoxicity against breast cancer cells.
    Kamal MM; Nazzal S
    Int J Pharm; 2018 Jan; 536(1):187-198. PubMed ID: 29195916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
    Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
    Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polymer microstructure on the docetaxel release and stability of polyurethane formulation.
    Shaikh M; Choudhury NR; Knott R; Kanwar JR; Garg S
    Eur J Pharm Biopharm; 2016 Apr; 101():82-9. PubMed ID: 26829379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.
    Wu Y; Levons J; Narang AS; Raghavan K; Rao VM
    AAPS PharmSciTech; 2011 Dec; 12(4):1248-63. PubMed ID: 21948318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid excipients - matrix agents for sustained drug delivery.
    Rosiaux Y; Jannin V; Hughes S; Marchaud D
    J Control Release; 2014 Aug; 188():18-30. PubMed ID: 24929038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
    Chadha R; Bhandari S
    J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
    Palma G; Conte C; Barbieri A; Bimonte S; Luciano A; Rea D; Ungaro F; Tirino P; Quaglia F; Arra C
    Int J Pharm; 2014 Oct; 473(1-2):55-63. PubMed ID: 24992317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro and In Vivo Assessment of Docetaxel Formulation Developed for Esophageal Stents.
    Shaikh M; Zhang H; Wang H; Guo X; Song Y; Kanwar JR; Garg S
    AAPS PharmSciTech; 2017 Jan; 18(1):130-137. PubMed ID: 26895019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A parenteral docetaxel-loaded lipid microsphere with decreased 7-epidocetaxel conversion in vitro and in vivo.
    Luo L; Wang X; Chen Q; Miao L; Zhuo X; Liu L; Xu J; Zhang Y; He H; Yin T; Tang X
    Eur J Pharm Sci; 2017 Nov; 109():638-649. PubMed ID: 28918930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective photothermal chemotherapy with docetaxel-loaded gold nanospheres in advanced prostate cancer.
    Shen Y; Ma Z; Chen F; Dong Q; Hu Q; Bai L; Chen J
    J Drug Target; 2015; 23(6):568-76. PubMed ID: 25738990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
    Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
    Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel hydrophobin-coated docetaxel nanoparticles for intravenous delivery: in vitro characteristics and in vivo performance.
    Fang G; Tang B; Liu Z; Gou J; Zhang Y; Xu H; Tang X
    Eur J Pharm Sci; 2014 Aug; 60():1-9. PubMed ID: 24815943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to accelerated drug-excipient compatibility testing.
    Sims JL; Carreira JA; Carrier DJ; Crabtree SR; Easton L; Hancock SA; Simcox CE
    Pharm Dev Technol; 2003; 8(2):119-26. PubMed ID: 12760562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.